drugset / Trial / NCT00970658

Efficacy and Safety of Salonsip Compared to Sabiá Plaster

NCT00970658 ↗

Phase 3 Unknown 70 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy in reducing signs and symptoms in patients with contusions, sprains, muscular injuries and injuries with less than 24 hours early or holders of myalgia, pain and tendonitis in regions miofasciais articulated with Salonsip compared to Sabiá plaster. It is clinical, open, multicenter, randomized, prospective and comparative, with patients entering at random. Patients will be included in sufficient quantity to achieve the minimum number of 70 evaluable patients.

Timeline

Start
2009-12
Primary completion
2010-01
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sabia Unknown — Topical
Subject Salonsip Unknown — Topical

Indications